4.3 Letter

Guidance on the management of Diabetic Ketoacidosis in the exceptional circumstances of the COVID-19 pandemic

Journal

DIABETIC MEDICINE
Volume 37, Issue 7, Pages 1214-1216

Publisher

WILEY
DOI: 10.1111/dme.14328

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available